Stay updated on XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Sign up to get notified when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.

Latest updates to the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page
- Check3 days agoChange DetectedThe site revision indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3** on the study details page.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision changed from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check75 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing the previous v3.4.0.SummaryDifference0.1%

Stay in the know with updates to XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XMT-1536 First-in-Human Study in NaPi2b-Expressing Cancers Clinical Trial page.